https://www.wsj.com/articles/covid-washington-officials-stocks-trading-markets-stimulus-11666192404 Skip to Main Content SubscribeSign In Search SubscribeSign In This copy is for your personal, non-commercial use only. Distribution and use of this material are governed by our Subscriber Agreement and by copyright law. For non-personal use or to order multiple copies, please contact Dow Jones Reprints at 1-800-843-0008 or visit www.djreprints.com. https://www.wsj.com/articles/ covid-washington-officials-stocks-trading-markets-stimulus-11666192404 * Capital Assets As Covid Hit, Washington Officials Traded Stocks With Exquisite Timing Some sold in January 2020 when the government began mobilizing against the threat. Others bought shares as a market-rescue plan was taking shape. A medical worker attended a hospitalized patient in Wuhan, China, epicenter of the Covid outbreak, in February 2020.[im-646468] A medical worker attended a hospitalized patient in Wuhan, China, epicenter of the Covid outbreak, in February 2020. Photo Illustration: WSJ; Photo: China Daily via Reuters By Rebecca Ballhaus , Joe Palazzolo , Brody Mullins , Chad Day and John West Oct. 19, 2022 11:17 am ET Listen to article (2 minutes) Federal officials working on the government response to Covid-19 made well-timed financial trades when the pandemic began--both as the markets plunged and as they rallied--a Wall Street Journal investigation found. In January 2020, the U.S. public was largely unaware of the threat posed by the virus spreading in China, but health officials were on high alert and girding for a crisis. [wsj-logo-b] Continue reading your article with a WSJ membership View Membership Options Already a member? Sign In Powered by Dow Jones * Customer Center * Subscriber Agreement * Privacy Notice * Cookie Notice * Do Not Sell My Personal Information * (c) 2022 Dow Jones & Company, Inc. All Rights Reserved. Copyright (c)2022 Dow Jones & Company, Inc. All Rights Reserved This copy is for your personal, non-commercial use only. Distribution and use of this material are governed by our Subscriber Agreement and by copyright law. For non-personal use or to order multiple copies, please contact Dow Jones Reprints at 1-800-843-0008 or visit www.djreprints.com.